T-cell responses to hepatitis B splice-generated protein of hepatitis B virus and inflammatory cytokines/chemokines in chronic hepatitis B patients. ANRS study: HB EP 02 HBSP-FIBRO

Journal of Viral Hepatitis

Volumn 19, Issue 12, 2012, Pages 872-880

  Bayard, F ^a,b,c   Godon, O ^a,b   Nalpas, B ^d   Costentin, C ^c,d,e   Zhu, R ^a,b   Soussan, P ^b   Vallet Pichard, A ^c,d,e   Fontaine, H ^c,d,e   Mallet, V ^c,d,e   Pol, S ^c,d,e   Michel, M L ^a,b,f  

^a Laboratoire de Pathogenèse des Virus de l'Hépatite B   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d INSTITUT COCHIN   (France)

^e université Paris Cité   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

cytokines; HBSP; hepatitis B; inflammation; T cell responses; viral infection

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CYTOKINE; EOTAXIN; EPITOPE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPATITIS B SPLICE GENERATED PROTEIN; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EX VIVO STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; LIVER BIOPSY; LIVER INJURY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; SUPERNATANT; T LYMPHOCYTE; VIRUS CAPSID; VIRUS LOAD;

ADULT; AGED; ALANINE TRANSAMINASE; CARRIER STATE; CELLS, CULTURED; CYTOKINES; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LEUKOCYTES, MONONUCLEAR; LIVER; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; VIRAL LOAD; VIRAL PROTEINS; YOUNG ADULT;

EID: 84868517857     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2012.01611.x     Document Type: Article

References (32)

1. Dienstag JL,. Hepatitis B virus infection. N Engl J Med 2008; 359 (14): 1486-1500.
2. Rehermann B, Nascimbeni M,. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5 (3): 215-229.
3. Chang JJ, Lewin SR,. Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol 2007; 85 (1): 16-23.
4. Rosmorduc O, Petit MA, Pol S, et al. In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA. Hepatology 1995; 22 (1): 10-19.
5. Terre S, Rosmorduc O, Kremsdorf D, Petit MA, Brechot C,. Reverse transcription and packaging of hepatitis B virus (HBV)-RNA generates in vivo defective serum HBV particles. J Hepatol 1991; 13 (Suppl 4): S42-S48.
6. Soussan P, Garreau F, Zylberberg H, Ferray C, Brechot C, Kremsdorf D,. In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA. J Clin Invest 2000; 105 (1): 55-60.
7. Soussan P, Pol J, Garreau F, et al. Expression of defective hepatitis B virus particles derived from singly spliced RNA is related to liver disease. J Infect Dis 2008; 198 (2): 218-225.
8. Soussan P, Tuveri R, Nalpas B, et al. The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis. J Hepatol 2003; 38 (3): 343-348.
9. Preiss S, Littlejohn M, Angus P, et al. Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance. Hepatology 2008; 48 (3): 741-749.
10. Chisari FV, Ferrari C,. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29-60.
11. Bertoletti A, Maini MK,. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr Opin Microbiol 2000; 3 (4): 387-392.
12. Rehermann B,. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses. Semin Liver Dis 2007; 27 (2): 152-160.
13. Maini MK, Boni C, Lee CK, et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000; 191 (8): 1269-1280.
14. Guidotti LG, Chisari FV,. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001; 19: 65-91.
15. Bertoletti A, D'Elios MM, Boni C, et al. Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 1997; 112 (1): 193-199.
16. Bataller R, Brenner DA,. Liver fibrosis. J Clin Invest 2005; 115 (2): 209-218.
17. Mancini-Bourgine M, Bayard F, Soussan P, et al. Hepatitis B Virus Splice-Generated Protein Induces T-Cell Responses in HLA-Transgenic Mice and Hepatitis B Virus-Infected Patients. J Virol 2007; 81 (10): 4963-4972.
18. EASL. Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009; 50 (2): 227-242.
19. Currier JR, Kuta EG, Turk E, et al. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. J Immunol Methods 2002; 260 (1-2): 157-172.
20. Webster GJ, Reignat S, Brown D, et al. Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol 2004; 78 (11): 5707-5719.
21. Wherry EJ, Ha SJ, Kaech SM, et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 2007; 27 (4): 670-684.
22. Das A, Hoare M, Davies N, et al. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med 2008; 205 (9): 2111-2124.
23. Weaver CT, Hatton RD, Mangan PR, Harrington LE,. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25: 821-852.
24. Zhang JY, Zhang Z, Lin F, et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010; 51 (1): 81-91.
25. Taub DD, Anver M, Oppenheim JJ, Longo DL, Murphy WJ,. T lymphocyte recruitment by interleukin-8 (IL-8). IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo. J Clin Invest 1996; 97 (8): 1931-1941.
26. Tan AT, Koh S, Goh W, et al. A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B. J Hepatol 2010; 52 (3): 330-339.
27. Dunn C, Brunetto M, Reynolds G, et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 2007; 204 (3): 667-680.
28. Robertson MJ,. Role of chemokines in the biology of natural killer cells. J Leukoc Biol 2002; 71 (2): 173-183.
29. Crane M, Oliver B, Matthews G, et al. Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy. J Infect Dis 2009; 199 (7): 974-981.
30. Romero AI, Lagging M, Westin J, et al. Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection. J Infect Dis 2006; 194 (7): 895-903.
31. Zeremski M, Dimova R, Brown Q, Jacobson IM, Markatou M, Talal AH,. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection. J Infect Dis 2009; 200 (11): 1774-1780.
32. Askarieh G, Alsio A, Pugnale P, et al. Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C. Hepatology 2010; 51 (5): 1523-1530.